Sou Hu Cai Jing·2025-06-29 21:48Group 1 - The core stock price of Fosun Pharma (600196) closed at 24.74 RMB on June 27, 2025, with a slight increase of 0.37% and a trading volume of 99,200 shares, resulting in a total transaction amount of 246 million RMB [1] - On June 27, 2025, the capital flow for Fosun Pharma showed a net inflow of 3.72 million RMB from institutional investors, accounting for 1.51% of the total transaction amount, while retail investors experienced a net outflow of 9.23 million RMB, representing 3.76% of the total transaction amount [2][4] - The company announced the repurchase of 810,300 H-shares at a price of 24.68 RMB per share on June 26, 2025, with a total expenditure of approximately 19.998 million RMB [3][4] Group 2 - As of June 19, 2025, Fosun Pharma had 2,100,531,773 shares issued (excluding treasury shares) and 17,957,052 treasury shares [3] - After the repurchase, the number of issued shares (excluding treasury shares) decreased to 2,099,721,473, while the total number of issued shares remained unchanged at 2,118,488,825 [3]